Literature DB >> 27858220

[Is the relationship between fear-avoidance cognitions and quality of life mediated by depressive symptoms?]

S Roch1, J Föllmer2, P Hampel2.   

Abstract

BACKGROUND: Chronic low back pain is often accompanied by fear-avoidance cognitions, increased depressive symptoms and decreased quality of life.
OBJECTIVE: Is the relationship between fear-avoidance cognitions and quality of life mediated by depressive symptoms?
METHODS: Mediation analyses were conducted to predict the long-term quality of life with depressive symptoms as mediator using longitudinal data from 131 patients.
RESULTS: Fear-avoidance cognitions prior to rehabilitation predicted the physical quality of life 24 months after rehabilitation, which was mediated by the degree of depressive symptoms 6 months after rehabilitation. The other assumed models could not be tested due to non-significant correlations between the model variables.
CONCLUSION: To improve the physical quality of life, depressive symptoms should be included into the treatment of chronic low back pain.

Entities:  

Keywords:  Chronic low back pain; Depressive symptoms; Fear-avoidance model (FAM); Mediation analysis; Quality of life

Mesh:

Year:  2017        PMID: 27858220     DOI: 10.1007/s00482-016-0174-x

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  11 in total

1.  Long-term effects of a cognitive-behavioral training program for the management of depressive symptoms among patients in orthopedic inpatient rehabilitation of chronic low back pain: a 2-year follow-up.

Authors:  Lisa Tlach; Petra Hampel
Journal:  Eur Spine J       Date:  2011-04-23       Impact factor: 3.134

2.  [Fear avoidance beliefs in patients with back pain. Psychometric properties of the German version of the FABQ].

Authors:  M Pfingsten
Journal:  Schmerz       Date:  2004-02       Impact factor: 1.107

Review 3.  The fear avoidance model disentangled: improving the clinical utility of the fear avoidance model.

Authors:  Tamar Pincus; Rob J E M Smeets; Maureen J Simmonds; Michael J L Sullivan
Journal:  Clin J Pain       Date:  2010 Nov-Dec       Impact factor: 3.442

Review 4.  [Comorbid psychological disorders in patients with chronic somatic diseases].

Authors:  M E Beutel; H Schulz
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2011-01       Impact factor: 1.513

5.  [Depressivity as mediator in the fear-avoidance model: a path analysis investigation of patients with chronic back pain].

Authors:  B Seekatz; K Meng; H Faller
Journal:  Schmerz       Date:  2013-12       Impact factor: 1.107

Review 6.  Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art.

Authors:  Johan W S Vlaeyen; Steven J Linton
Journal:  Pain       Date:  2000-04       Impact factor: 6.961

7.  [Concerning the impact of psychological comorbidity for chronic back pain: frequency, reduced earning capacity pension and rehabilitation aftercare in the course of the rehabilitation cohorts 2002–2009].

Authors:  C Schmidt; S Bernert; K Spyra
Journal:  Rehabilitation (Stuttg)       Date:  2014-12       Impact factor: 1.113

8.  [Epidemiology of comorbid mental disorders in rehabilitation patients with musculosceletal and cardiovascular diseases].

Authors:  M Härter; H Baumeister; K Reuter; A Wunsch; J Bengel
Journal:  Rehabilitation (Stuttg)       Date:  2002-12       Impact factor: 1.113

Review 9.  [Multimodal pain therapy for treatment of chronic pain syndrome. Consensus paper of the ad hoc commission on multimodal interdisciplinary pain management of the German Pain Society on treatment contents].

Authors:  B Arnold; T Brinkschmidt; H-R Casser; A Diezemann; I Gralow; D Irnich; U Kaiser; B Klasen; K Klimczyk; J Lutz; B Nagel; M Pfingsten; R Sabatowski; R Schesser; M Schiltenwolf; D Seeger; W Söllner
Journal:  Schmerz       Date:  2014-10       Impact factor: 1.107

10.  Chronic back pain and major depression in the general Canadian population.

Authors:  Shawn R Currie; JianLi Wang
Journal:  Pain       Date:  2004-01       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.